http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-12912000-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16 |
| filingDate | 1999-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_274dd53576c2ff83758468a1c49d96cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9aecc120b28d71ddbe3a5da7f134b24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bc9571efaf04ea0baea6a9b86c21edf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0773d412e783f5af25b5c23f84fbd03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_017421540dfb26ff68c96d2331d30a3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb12199109dcba30b8a8c9b8d069d955 |
| publicationDate | 2001-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SK-12912000-A3 |
| titleOfInvention | 6,9-DISUBSTITATED 2- [TRANS- (4-AMINOCYCLOHEXYL) AMINO] PURINS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USE |
| abstract | The present invention provides novel compounds of formula (I) wherein R is selected from the group consisting of R2, R2NH-, or H2N-R3- wherein R2 is selected from the group consisting of C1-C8 alkyl and formula (II), wherein Z is selected from the group consisting of phenyl, heterocycle and cycloalkyl, each R4 is independently hydrogen or C1-C4 alkyl, and n is an integer 1-8; wherein each C1-C8 alkyl and Z is optionally substituted with 1 to 3 substituents, which may be the same or different, selected from the group consisting of Hal, OH, and C1-C4 alkyl; R3 is C1-C8 alkylene; and R1 is selected from the group consisting of cyclopentyl and isopropyl, and the pharmaceutically acceptable salts, optical isomers, and hydrates thereof. In addition, the present invention provides a method of inhibiting cell cycle progression. More specifically, the present invention provides a method of inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms. In addition, the present invention provides a composition comprising an assayable amount of a compound of formula (I) in admixture or otherwise in association with an inert carrier. The present invention also provides a pharmaceutical composition comprising an effective inhibitory amount of a compound of formula (I) in admixture or otherwise in association with one or more pharmaceutically acceptable carriers or excipients. |
| priorityDate | 1998-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1571.